𝔖 Bobbio Scriptorium
✦   LIBER   ✦

260 POSTER The need for DXA assessment of breast cancer patients following 5years of tamoxifen prior to starting an aromatase inhibitor

✍ Scribed by K. Whannel; A. Mclellan; C.R. Wilson; J.C. Doughty

Book ID
117568855
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
82 KB
Volume
32
Category
Article
ISSN
0748-7983

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NSABP B-42: A Clinical Trial to Determin
NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared with Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor—Positive Breast Cancer
✍ Eleftherios P. Mamounas; Barry Lembersky; Jong-Hyeon Jeong; Walter Cronin; Barba 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB